Navigation Links
In Focus with Martin Sheen Exploring the Advances of Molecular Medicine
Date:3/9/2013

Hollywood, CA (PRWEB) March 08, 2013

The producers of In Focus with Martin Sheen announce a May debut for a new report into how molecular science has become a key component in the battle against deadly disease.

In Focus Martin Sheen PBS is an independently produced television series airing in markets around the country on public television. The program is hosted by the legendary Martin Sheen, who is about to embark on his second half-century in American entertainment. Mr. Sheen has developed a reputation as one of Hollywood’s most respected actors during a career that includes more than 60 film appearances.

In May, In Focus Martin Sheen will bring public television audiences an exciting look at the microscopic world. Researchers are using powerful instruments to visualize diseases like Parkinson’s, Alzheimer’s, AIDS, and cancer at the molecular level, uncovering the building blocks of disease.

In this new report, In Focus will be talking to researchers about how this new insight is helping to craft new treatments that attack diseases at their very foundations, bringing new hope to patients and their families.

The producers of In Focus with Martin Sheen are hoping to debut the new report in May. Viewers can find air times and dates by checking their local listings. For more information about the reports or to offer other ideas related to this topic, In Focus with Martin Sheen can be reached through the show’s official website at infocusptv.com or on Facebook at facebook.com/InFocusMartinSheen.

Read the full story at http://www.prweb.com/releases/2013/3/prweb10511712.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1

Related biology technology :

1. Array Biopharma and Global Blood Therapeutics Announce Drug Discovery Collaboration Focused on Hematology
2. Elsevier and the Emergency Nurses Association Launch New eLearning Course Focused on Psychiatric Emergencies
3. DebMed Brings Focus on Patient Safety to HIMSS 2013
4. Avenida Suites Brazil Sponsors 4th Annual Global HR News Conference in Sao Paulo Focused on Global Mobility Workforce Issues
5. SPIE Advanced Lithography will Bring Industry Focus to Next-generation Tools and Systems
6. Cieri Media Announces New Science Series 'Bright Ideas' Focusing on Latest Inventions
7. SeraCare Life Sciences Sharpens Focus on Diagnostics Industry
8. Chemical Imaging Spectroscopy is the Focus for Pittcon 2013 Waters Symposium
9. UroToday Launches New Prostate Cancer Focused Content Including Immunotherapy for Metastatic Castration-resistant Patients
10. OneMedPlace Releases Update to Research Report on Amarantus Biosciences Focused on New Positive Ischemic Heart Disease Efficacy Data for MANF in Animals
11. New Crowdfunding Platform, ScitechStarter, Focuses on Science and Technology Innovators
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 24, 2017  Infectex Ltd., a ... today announced positive results of a Phase 2b-3 clinical ... regimen in patients with multidrug-resistant pulmonary tuberculosis (MDR-TB). SQ109 ... at Sequella, Inc. ( USA ) and ... A total of 140 patients were enrolled in a ...
(Date:3/24/2017)... March 24, 2017 Agenus Inc. (NASDAQ: AGEN), ... antibodies and cancer vaccines, today announced participation at the ...  Annual William Blair and Maidstone Life Sciences conference "Cancer ... in New York, NY . Agenus ... 29 at 9:40 am: Robert B. Stein , ...
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... NetworkNewsWire Editorial Coverage  ... Cancer remains one of the world,s ... systems, in terms of costs and resources. However, as the ... of innovative and efficient therapies that demonstrate higher chances of ... cancer treatments, a growing number of patients receiving immuno-oncology therapies ...
Breaking Biology Technology:
(Date:2/24/2017)... -- EyeLock LLC, a leader of iris-based identity authentication ... solution on the latest Qualcomm® Snapdragon™ 835 mobile ... Congress 2017 (February 27 – March 2, ... Stand 3E10. The Snapdragon 835 ... combination of hardware, software and biometrics technologies ...
(Date:2/21/2017)... , February 21, 2017 ... 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr als ... einige Hindernisse zu überwinden gilt, um diese Prognose zu ... ... anderem die Mobilisierung der finanziellen Mittel für die Biobank, ...
(Date:2/13/2017)... FRANCISCO , Feb. 13, 2017  RSA ... centralized platform that is designed to enhance fraud ... latest release in the RSA Fraud & Risk ... enable organizations to leverage additional insights from internal ... tools to better protect their customers from targeted ...
Breaking Biology News(10 mins):